Atrasentan in patients with IgA nephropathy (ALIGN): final 2&#xb7;5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Erectile and Sexual Functions and Dysfunctions

Efficacy and safety of simenafil in men with erectile dysfunction: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group, phase 3 trial

J Sex Med

Yang Y, Zhang X, Jiang T, Zhao L, Li F, Yao W, Deng J, Zhang X, Yang J, Ji Z, Tong Z, Chen Y, Wang Z, Juan J, Duan H, Jiang H

doi: 10.1093/jsxmed/qdaf109

Further Publications Urology

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Lancet

Heerspink HJL, Cardona JF, Jolly S, Pergola PE, de Sousa-Amorim E, Eriksson AL, Fredholm M, Gasparyan SB, Guzman NJ, Hartleib-Geschwindner J, Jiang Y, Leonsson-Zachrisson M, Mark PB, MIRO-CKD study investigators

doi: 10.1016/S0140-6736(25)02014-8

Pregnancy and Childbirth

Ovarian stimulation with follitropin delta is safe and effective: Results from the RITA randomized, double-blind, placebo-controlled trials

Fertil Steril

Scheiber MD, Doody KJ, Foster ED, Grover SA, Heiser PW, RITA-1 and RITA-2 (Recombinant FSH Investigation in the Treatment of Infertility with ART) trial group

doi: 10.1016/j.fertnstert.2025.07.032

Erectile and Sexual Functions and Dysfunctions

A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials

J Sex Med

Salonia A, Bettocchi C, Burnett A, Corona G, Fode M, Hassan T, Minhas S, Mulhall JP, Sadeghi-Nejad H, Vignesh SO, Wang R, Jannini EA

doi: 10.1093/jsxmed/qdag176

Urinary Tract Infections (UTI)

Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial

Lancet

Takahashi S, Tateda K, Yanagihara K, Huang H, Doi Y, Yasuda M, Matsumoto K, Sumiya M, Takaya R, Suwada K, Kamiyabu S, Sasagawa Y, Minamida T, Kato S, Kondo K, Naruse T, Mikamo H

doi: 10.1016/S0140-6736(26)00596-9

Further Publications Gynecology

A Phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp to reduce the incidence of recurrent vulvovaginal candidiasis

Am J Obstet Gynecol

Goje O, Azie NE, Angulo DA, Sobel R, Nyirjesy P, Sobel JD

doi: 10.1016/j.ajog.2025.07.040

Further Publications Urology

Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial

Eur Urol

Tikkinen KAO, Marcucci M, Halme ALE, Ofori SN, Borges FK, Kanstrup CTB, Park LJ, Tondroanamag F, Kilpeläinen TP, Tornberg SV, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Martinez-Zapata MJ, Wang CY, Xavier DB, Wang MK, Szczeklik W, Leslie K, Lavallee LT, Breau RH, Balasubramanian K, Devereaux PJ

doi: 10.1016/j.eururo.2026.03.019

Further Publications Urology

Patient-reported outcome measures of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: results of the STent Or NEphrostomy (STONE) randomised controlled trial

BJU Int

Schuil HW, Hendriks N, Duijnhoven RG, Oskam BCH, Arends TJH, Duijvesz D, Horsch AD, van der Heij B, Tjiam IM, van Overhagen H, Lamers ABGN, van Delden OM, Scheepens WA, Drossaerts JMA, d'Ancona FCH, Boering S, van Uhm JIM, van der Meer RW, van Roijen JH, de Kiefte M, Hendrikx AJM, Weltings S, Pelger RCM, Beerlage HP, Schout BMA, Kamphuis GM

doi: 10.1111/bju.70249

Further Publications Urology

Single-dose Versus 3-day Antimicrobial Prophylaxis in Transurethral Resection or Photoselective Vaporization of the Prostate: A Multicenter, Randomized, Placebo Controlled Trial (CITrUS Trial)

Eur Urol Focus

Bausch K, Speich B, Vogt DR, Hemkens LG, Dreher M, Kwiatkowski M, Subotic S, Ardelt P, Bossard P, Hermanns T, Bruni N, Wyler S, Prause L, Merz SC, Engesser C, Roth J, Widmer AF, Seifert HH

doi: 10.1016/j.euf.2025.08.009

Gynecology · Urology

Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Related content

Efficacy and safety of simenafil in men with erectile dysfunction: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group, phase 3 trial

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Ovarian stimulation with follitropin delta is safe and effective: Results from the RITA randomized, double-blind, placebo-controlled trials

A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials

Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial

A Phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp to reduce the incidence of recurrent vulvovaginal candidiasis

Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 Trial

Patient-reported outcome measures of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: results of the STent Or NEphrostomy (STONE) randomised controlled trial

Single-dose Versus 3-day Antimicrobial Prophylaxis in Transurethral Resection or Photoselective Vaporization of the Prostate: A Multicenter, Randomized, Placebo Controlled Trial (CITrUS Trial)